IGM Biosciences Inc (FRA:1K0)
€ 13.9 -0.4 (-2.8%) Market Cap: 863.57 Mil Enterprise Value: 663.99 Mil PE Ratio: 0 PB Ratio: 7.62 GF Score: 29/100

IGM Biosciences Inc at Morgan Stanley Global Healthcare Conference (Virtual) Transcript

Sep 13, 2021 / 06:45PM GMT
Release Date Price: €61 (+0.83%)
Michael Eric Ulz
Morgan Stanley, Research Division - Equity Analyst

Great. Good afternoon, and thanks for joining us at the Morgan Stanley Global Healthcare Conference. I'm Mike Ulz, the biotech analyst here, and it's my pleasure to introduce Fred Schwarzer, CEO from IGM Biosciences. And just a quick reminder, the format for today is a fireside chat. But if you have questions, please feel free to submit them through the portal, and we will be sure to address them in our discussion.

Just quickly before we get started, I need to read a quick disclaimer for important disclosures. Please see the Morgan Stanley research disclosure website at www.morganstanley.com/researchdisclosures. And if you have any questions, please reach out to your Morgan Stanley sales representative.

So with that, we'll just get right into the Q&A. Fred, thanks for joining us today. Really appreciate it.

Fred M. Schwarzer
IGM Biosciences, Inc. - CEO, President & Director

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot